Enjoy complimentary customisation on priority with our Enterprise License!
The global vaccine research market size is estimated to grow by USD 17.59 billion at a CAGR of 9.88% between 2022 and 2027.
An important factor driving the growth of the global vaccine research market is the research for novel adjuvants and vaccine delivery technologies to improve vaccine efficacy and stability. Adjuvants, which are used to improve the immune system response, are chemicals that are injected into vaccines. New adjuvants and dosage methods are under investigation to improve the immune response caused by vaccines. The immune response is strengthened by this highly focused delivery mechanism, which boosts the efficacy of the vaccine. Researchers are trying to improve vaccine formulations, enhance their efficacy and possibly reduce the number of vaccines required for each person. These developments will help meet the global demand for effective vaccinations against many infectious illnesses by enabling the production of more effective and potent vaccines.
Technavio has segmented the market into End-user, Age Groups, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges.
To learn more about this report, Request Free Sample
Public
The market share growth by the public segment will be significant during the forecast period. Government organizations fall under the public end-user segment. There are various government organizations that are involved in the research of vaccines, such as the US National Institute of Allergy and Infectious Diseases (NIAID) and the US National Institutes of Health (NIH). The efforts taken by governments from around the world to develop and put into use a number of COVID-19 vaccines have resulted, in particular from massive and sustained investment which has been made over many decades.
Get a glance at the market contribution of various segments View a PDF Sample
The public segment was valued at USD 11.31 billion in 2017. Governments have largely funded and invested in each and every aspect, starting from the basic science and pre-clinical development to the clinical trials for these vaccines. Based on a wide range of possible sources and the timing of data collection, it is significantly different in terms of estimates of actual government expenditure for the R&D of COVID-19 vaccines.
Private pharmaceutical companies have been at the forefront of discovering, developing, and delivering a range of effective vaccines to help prevent disease around the world for more than 100 years. Various vaccine R&D strategies, e.g. collaboration with governments, academics, and NGOs all over the world, are constantly being implemented by vendors. There has been a rise in private R&D spending as well as the introduction of new vaccines. The outbreak of the COVID-19 pandemic has stimulated the R&D of vaccines to contain the COVID-19 pandemic. In addition to R&D spending by the private sector, governments across the world have provided support to the private sector to develop vaccines to contain the pandemic.
The pediatric age group is of high significance in the global vaccine research market due to the sustained emphasis on the creation and delivery of vaccines for children. The health of children across the world has been greatly improved and as a result of the global vaccination programs for children, different infectious childhood diseases have been eradicated. The market environment for pediatric vaccinations is characterized by rising R&D spending, stringent regulatory standards, and rising demand for vaccines that are both safe and efficacious for children. New vaccines to prevent diseases such as rotavirus and pneumococcal infections that cause high morbidity and mortality in children are also being developed. The emphasis on pediatric vaccinations also underlines the dedication to preserving the health and welfare of children, which, in turn, will drive the growth of the market in focus during the forecast period.
The pediatric age group is of high significance in the global vaccine research market due to the sustained emphasis on the creation and delivery of vaccines for children. Thanks to childhood vaccination programs in the world, children's health worldwide has greatly improved, and infectious diseases such as measles have been eliminated. The market environment for pediatric vaccinations is characterized by rising R&D spending, stringent regulatory standards, and rising demand for vaccines that are both safe and efficacious for children. For diseases such as rotavirus or pneumococcal infections with high morbidity and mortality in children, new vaccines are also being developed. The emphasis on pediatric vaccinations also underlines the dedication to preserving the health and welfare of children, which, in turn, will drive the growth of the market in focus during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America holds one of the largest shares of the global vaccine research market, primarily due to the strong prevalence of infectious diseases, such as influenza, hepatitis A, hepatitis B, HIV, measles, malaria, and tuberculosis, and non-infectious diseases, such as cancer. In developed countries in this region, the number of infectious and uninfectious diseases has been steadily increasing. Although there has been a gradual reduction in the number of infections caused by mumps, measles, and rubella MMR across the United States, they are still not fully eradicated. Therefore, the government in the region, in collaboration with several private players, has worked toward the betterment of R and D to neutralize the impact of such infectious diseases.
The R and D of COVID-19 vaccines in the region spurred the growth of the market in focus in 2020-2021. Furthermore, the market witnessed high demand for COVID-19 vaccines in North America in 2020 due to the significantly high number of COVID-19 cases. Therefore, the R&D activities of COVID-19 vaccines in the region have increased due to a large number of cases of COVID-19. Vaccine research infrastructure and capacity in the area have increased as a result of expert knowledge acquired during the development of different COVID-19 vaccines, especially in the US, which will encourage future growth in vaccine research, including improvements in vaccine technology, improved readiness for newly emerging infectious diseases, and higher public confidence in vaccines, thereby driving the growth of the regional market during the forecast period.
Buy Now Full Report and Discover More
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market vendors, including:
Abbott Laboratories - The company offers vaccine research for therapy areas such as Anti incentives, Cardio Diabeto and Neuro Psychiat.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key trends, and challenges.
The adoption of AI to speed up the R&D of vaccines is the primary trend in vaccine research market drivers. Artificial intelligence has the potential to lead to new vaccines being discovered and developed. AI helps convert data into valuable knowledge to understand the disease to be treated, design better clinical trials, and speed up the way we design and develop vaccines. In order to increase the productivity of R&D, AI tools assist vaccine researchers in their discovery of new biological insights.
Moreover, AI is also used for analyzing /images in real time and has helped researchers try to pick out genetic mutations and variations. This way, the virus can be identified with new variants and mutations. In this way, artificial intelligence can be a major tool for developing vaccines. Hence, the adoption of Ai in the R&D of vaccines is expected to be a significant trend driving the growth of the market in focus during the forecast period.
The high cost of vaccine research, development, and manufacturing is a major challenge in the vaccine research market. Vaccine development has a major role to play in the fight against many of the life-threatening diseases. Despite this achievement, there is still a great need for new vaccines. However, global achievements such as the eradication of smallpox have been slow due to the need for huge investments in the development and manufacture of vaccines. In order to develop vaccines that can contribute to the world's preparedness against and prevention of epidemics and pandemics caused by infection, a Consortium for Epidemiological Preparedness Innovations has been created under the name CEPI.
Moreover, the cost of vaccines is expected to be high for humans due to the costs involved in research, development, and manufacturing. The high cost of vaccines has a negative impact on patient compliance and adherence to vaccine protocols, which limits market growth. Therefore, it has become important to develop vaccines with novel routes of administration coupled with low cost. Thus, the high cost of vaccine research, development, and manufacturing will have a negative impact on the growth of the global vaccine research market during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Vaccine Research Market Customer Landscape
The vaccine research market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
|
Vaccine Research Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
160 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.88% |
|
Market growth 2023-2027 |
USD 17.59 billion |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
8.8 |
|
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 41% |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Creative Biogene |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Age Group
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Get the report (PDF) sent to your email within minutes.
